期刊文献+

老年慢性心力衰竭患者肺部感染后血清胆碱酯酶和胱抑素C及炎症因子分析 被引量:25

Relationship between serum cholinesterase,cystatin C,inflammation and prognosis in elderly patients with chronic heart failure accompanying pulmonary infection
原文传递
导出
摘要 目的探讨老年慢性心力衰竭伴肺部感染患者血清胆碱酯酶(CHE)、胱抑素C(Cys C)、炎症因子与预后的关系。方法选取2017年1-8月医院收治的慢性心力衰竭伴肺部感染患者100例设为感染组,选取100例单纯慢性心力衰竭患者为无感染组,入院后检测血清CHE、Cys C和C-反应蛋白(CRP)、B型脑钠肽(BNP)水平,观察患者住院期间及随访出院后3个月内不良心脏事件(Major Adverse Cardiovascular Events,MACE)发生情况。结果感染组患者Cys C、PCT、CRP、BNP分别为(1.98±1.62)mg/dl、(1.71±0.72)mg/ml、(34.89±11.27)、mg/L、(6 731.60±2 348.55)ng/L均高于无感染组,血清CHE为(3 833.81±2 155.23)U/L低于无感染组(P <0.001);感染组预后不良率为36.00%(36/100)高于无感染组(P=0.019);感染组预后良好患者Cys C、PCT、CRP、BNP分别为(1.32±1.03)mg/dl、(1.45±0.67)mg/ml、(24.62±10.41)mg/L、(5 742.57±2 056.14)ng/L低于预后不良患者,血清CHE为(5 234.33±2 345.67)高于预后不良患者(P<0.05);无感染组预后良好患者Cys C、PCT、CRP、BNP分别为(1.01±0.58)mg/dl、(0.35±0.17)mg/ml、(8.34±5.21)mg/L、(1 878.44±1 634.83)ng/L低于预后不良患者,血清CHE为(6 224.33±2 215.47)U/L高于预后不良患者(P<0.05)。结论老年慢性心力衰竭伴肺部感染患者血清CHE降低,Cys C与炎症指标升高,预后不良患者各指标变化更为明显,具有一定的临床价值。 OBJECTIVE To explore the relationship between serum cholinesterase(CHE),cystatin C(Cys C),inflammatory factors and prognosis in elderly patients with chronic heart failure accompanying pulmonary infection.METHODS We included 100 cases of elderly patients with chronic heart failure accompanying pulmonary infection admitted to the hospital from Jan.2017 to Aug.2017 as the infected group,and 100 cases of elderly patients with chronic heart failure as the uninfected group.The CHE,Cys C,procalcitonin(PCT),C-reactive protein(CRP),and B-type natriuretic peptide(BNP)levels were measured at admission in both groups.The incidence of major adverse cardiac events(MACE)occurred during hospital stay and within 3 months after discharge was observed in both groups.RESULTS Cys C,PCT,CRP and BNP of the infected group were(1.98±1.62)mg/dl,(1.71±0.72)mg/ml,(34.89±11.27)mg/L,and(6 731.60±2 348.55)ng/L,higher than those of the uninfected group.CHE of the infected group was(3 833.81±2 155.23)U/L,significantly lower than that of the uninfected group(P <0.001).There were 36 patients with poor prognosis in the infected group(36.00%),the incidence was significantly higher than that of the uninfected group(P=0.019).Cys C was(1.32±1.03)mg/dl,PCT was(1.45±0.67)mg/ml,CRP was(24.62±10.41)mg/L,BNP was(5 742.57±2 056.14)ng/L in the patients with good prognosis of the infected group,significantly lower than those in the patients with poor prognosis,whereas the serum CHE of(5 234.33±2 345.67)U/L in infected patients with good prognosis was significantly higher than that in the infected patients with poor prognosis(P<0.05).Cys C was(1.01±0.58)mg/dl,PCT was(0.35±0.17)mg/ml,CRP was(8.34±5.21)mg/L,BNP was(1 878.44±1 634.83)ng/L in patients with good prognosis of the uninfected group,significantly lower than those in the patients with poor prognosis(P<0.05),whereas the serum CHE of(6 224.33±2 215.47)U/L in uninfected patients with good prognosis was significantly higher than that in the uninfected patients with poor prognosis(P<0.05).CONCLUSION The serum CHE level obviously decreases in elderly patients with chronic heart failure accompanying pulmonary infection,Cys C and inflammatory cytokines significantly increase,and the changes of the above indicators are more obvious in patients with poor prognosis,indicating a certain value of these indicators.
作者 张淑艳 申洁 赵文慧 ZHANG Shu-yan;SHEN Jie;ZHAO Wen-hui(Hebi College of Vocation and Technology,Hebi,Henan 458030,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2019年第3期365-368,共4页 Chinese Journal of Nosocomiology
基金 河南省医学科技攻关计划基金资助项目(201604397)
关键词 慢性心力衰竭 肺部感染 胆碱酯酶 胱抑素C 炎症 预后 Chronic heart failure Pulmonary infection Cholinesterase Cystatin C Inflammation Prognosis
  • 相关文献

参考文献5

二级参考文献90

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2刘尊齐,崔连群.慢性心力衰竭患者血清肌钙蛋白I与心肌重构的相关性研究[J].中华心血管病杂志,2006,34(5):437-439. 被引量:31
  • 3Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 4Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 5Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 6Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 7Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 8Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 9Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 10Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.

共引文献3764

同被引文献238

引证文献25

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部